CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody–associated vasculitis

CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody–associated vasculitis

Abstract Objective The present cohort study aimed to evaluate the value of CCL23 in diagnosis, disease activity, and prognosis in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Methods CCL23 levels in serum samples from 317 patients with AAV and 83 healthy controls (H...

Full description

Saved in:

Bibliographic Details
Main Authors:	Weiwei Hao, Qianqian Liu, Xiaoping Li, Yiran Xu, Wenjuan Guan, Lei Zhang, Fang Dong, Wenjun Cao, Shengyun Liu, Wei Li
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Series:	Arthritis Research & Therapy
Subjects:	ANCA-associated vasculitis CCL23 Biomarker Renal involvement Prognosis
Online Access:	https://doi.org/10.1186/s13075-025-03552-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pediatric antineutrophil cytoplasmic antibody-associated vasculitis: A review on pulmonary manifestations, management, and outcomes
by: Chien-Heng Lin, et al.
Published: (2024-09-01)

Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis
by: Tania Salehi, et al.
Published: (2025-07-01)

Cervical myelopathy as an atypical presentation of antineutrophil cytoplasmic antibody-associated vasculitis in a patient affected by silicosis: a case report and literature overview
by: S. Grazzini, et al.
Published: (2024-09-01)

Damage to the organ of hearing and upper respiratory tract in vasculitis associated with antineutrophil cytoplasmic antibodies
by: A. A. Klimenko, et al.
Published: (2024-08-01)

Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
by: Reza Zonozi, et al.
Published: (2024-06-01)

Infective endocarditis mimicking antineutrophil-cytoplasmic-antibody-associated vasculitis with glomerulonephritis: a case report
by: Ahmad Matarneh, et al.
Published: (2025-08-01)

Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
by: Stephen P. McAdoo, et al.
Published: (2025-06-01)

On the epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in the adult population of Russia
by: O. N. Egorova, et al.
Published: (2025-06-01)

Development of a Kidney Prognostic Score in a Japanese Cohort of Patients With Antineutrophil Cytoplasmic Autoantibody Vasculitis
by: Rei Takeda, et al.
Published: (2024-03-01)

Liver biopsy revealing anti-neutrophil cytoplasmic antibody-associated vasculitis: a tale for a challenging diagnosis
by: Bahaeddine Lahbacha, et al.
Published: (2024-12-01)

Clinical Presentation and Outcomes of Antineutrophil Cytoplasmic Autoantibody–Negative Pauci-Immune Glomerulonephritis
by: Lauren Floyd, et al.
Published: (2025-05-01)

Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis in chronic Hepatitis B: Unraveling the immune puzzle - a rare case report with review of literature
by: Suresh Bhagoowani, et al.
Published: (2024-01-01)

Kidney Transplantation Improves Survival in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides With End-Stage Kidney Disease
by: Benoît Brilland, et al.
Published: (2025-05-01)

Investigating potential biomarkers associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis using Mendelian randomization and transcriptomic analysis
by: Yujia Wang, et al.
Published: (2025-08-01)

Predictive Factors of Renal Recovery and Progression to End-Stage Kidney Disease in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis With Severe Kidney Disease
by: Marta Casal Moura, et al.
Published: (2024-05-01)

Pulmonary and Renal Predictors of Mortality in ANCA-Associated Vasculitis: A Regional Experience from Türkiye
by: Dilara Bulut Gökten, et al.
Published: (2025-06-01)

Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
by: Maria A.C. Wester Trejo, et al.
Published: (2025-02-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
by: Sunil Kapur, et al.
Published: (2021-01-01)

A rare adverse event of atorvastatin inducing leukocytoclastic vasculitis with ANCA‐negative (Anti‐Neutrophil cytoplasmic antibody) case report and literature review
by: Nehemias Guevara‐Rodriguez, et al.
Published: (2023-03-01)

Survey on Plasmapheresis Practices in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis: Insights From Two Clinical Case Studies
by: Cyril Mousseaux, et al.
Published: (2025-04-01)

Development of a Nomogram Model to Predict Mortality in ANCA‐Associated Vasculitis Patients With Pulmonary Involvement
by: Qifang Guo, et al.
Published: (2025-04-01)

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
by: Mitchell Salke, et al.
Published: (2025-06-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
by: E. N. Vorkel, et al.
Published: (2024-12-01)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
by: E. N. Vorkel, et al.
Published: (2024-08-01)

Clinical analysis of 41 cases of antineutrophil cytoplasmic antibody associated vasculitis
by: GAO Qi, et al.
Published: (2018-01-01)

“Normal” Glomerular Score Correlates With Outcomes in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis With Glomerulonephritis
by: Marta Casal Moura, et al.
Published: (2025-02-01)

Clinical perspective on serum periostin in antineutrophil-cytoplasmic antibody-associated vasculitis
by: Taejun Yoon, et al.
Published: (2025-05-01)

Human cytomegalovirus UL23 inhibits immune cell migration and blocks antiviral immune cell responses by reducing the expression of chemokines CCL2 and CCL5
by: Hankun Wang, et al.
Published: (2025-12-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

ANCA-associated Leucocytoclastic Vasculitis presenting with Bronchiectasis, GI Involvement and Hypertensive Urgency: A Complex Case without Renal Involvement
by: N. M. M. Risly, et al.
Published: (2024-12-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
by: B N Shiva Prasad, et al.
Published: (2021-01-01)

Recurrent strokes as the sole manifestation of antineutrophil cytoplasmic antibody associated vasculitis in a patientwith panuveitis: a case report
by: Hadeel Seraj, et al.
Published: (2025-02-01)

Serum interleukin-18 level in patients with antineutrophil cytoplasmic antibodies associated vasculitis and implication
by: CAI Juan, et al.
Published: (2015-01-01)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
by: O. N. Egorova, et al.
Published: (2024-10-01)

Granulomatosis with polyangiitis with severe lung involvement: efficacy of anti-B cell therapy with Rituximab
by: T. V. Beketova, et al.
Published: (2021-07-01)

Reclassification of the overlap syndrome of Behçet’s disease and antineutrophil cytoplasmic antibody-associated vasculitis in patients with Behçet’s disease
by: Tae Geom Lee, et al.
Published: (2025-01-01)

Clinical Significance of Peripheral Arterial Disease Evaluation in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Jeong Yeop Whang, et al.
Published: (2025-06-01)

Avacopan in Anti-Neutrophil Cytoplasmic Autoantibodies–Associated Vasculitis in a Real-World Setting
by: Jonas Zimmermann, et al.
Published: (2024-09-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)